Osborne Clarke advised the syndicate of investors on the deal.Tagworks Pharmaceuticals BV announced a $65 million Series A financing led by Ysios Capital and Gilde Healthcare with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
